All Sections
Welcome guest, you have 3 views left. | Register | Sign In

NH Angle is a news and information aggregation by staff and audience of the New Hampshire Union Leader, The Goffstown News, The Bedford Bulletin, The Hooksett Banner and The Salem Observer. Share a news link here or comment on this item below.

New hepatitis C wonder drug shakes up the health care industry with remarkable success and $1,000/pill price

In December 2013, Sovaldi won approval from the U.S. Food and Drug Administration, and Roth, of San Rafael, Calif., was placed on a 24-week treatment regimen. The cost: $168,000, or an eye-popping $1,000 per pill. The company says Sovaldiís price reflects its 90 percent-plus cure rate for hepatitis C and the savings that produces by cutting patientsí long-term treatment costs, which can include hospitalizations, surgeries and even liver transplants.



To improve the chance of seeing your comment posted here or published in the New Hampshire Union Leader:

  • Identify yourself. Accounts using fake or incomplete names are suspended regardless of the quality of posts.
  • Say something new, stay on topic, keep it short.
  • Links to outside URLs are discouraged, if used they should be on topic.
  • Avoid comments in bad taste, write well, avoid using all capital letters
  • Don't cite facts about individuals or businesses without providing a means to verify the claim
  • If you see an objectionable comment please click the "Report Abuse" button and be sure to tell us why.

Note: Comments are the opinion of the respective poster and not of the publisher.

Be the first to comment.

Post a comment

You must sign in before you can post comments. If you are experiencing issues with your account please e-mail

Most Popular

Follow us on Twitter Follow us on Facebook Follow our RSS feed
Union Leader app for Apple iPad or Android *
Click to download from Apple Apps StoreClick to download from Android Marketplace
* e-Edition subscription required